PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Regence BlueShieldAll Plans · Coverage · Laboratory & Genetics · Transplant Surgery, Cardiology, NephrologyMedium impact

Laboratory Tests for Organ Transplant Rejection

Effective date
Oct 1, 2026
Identified
Sep 2, 2026

Summary

Laboratory tests for organ transplant rejection are used to screen for, estimate risk for, detect, or rule out rejection after organ transplantation. Peripheral blood gene expression profiling, such as AlloMap, may be considered medically necessary in heart transplant recipients who are at least 15 years old, at least 2 months post heart transplant, have no documented signs or symptoms of heart transplant rejection, and have no history of treatment for heart transplant rejection. Gene expression profiling for patients outside those criteria or for organs other than the heart is investigational, as are volatile organic compound breath tests for heart rejection, donor-derived cell-free DNA tests, simultaneous donor-derived cell-free DNA and gene expression testing, recipient lymphocyte response tests in cell culture for renal, liver, and small bowel transplants, gene expression profiling on biopsy tissue, urinary CXCL10 testing after renal transplant, and serum non-HLA autoantibody tests.

Get alerts when payers change rules like this one

We check Regence BlueShield and other payers every day and email you when a change matches your specialty and state.

Get Regence BlueShield alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01Already effective October 1, 2026: Billing team should submit for review, for heart transplant gene expression profiling, the name of the test, the relevant billing codes, and the related medical records, including the history and physical exam and the date of heart transplant.
02Clinical documentation must support that the patient is at least 15 years old, at least 2 months post heart transplant, has no documented signs or symptoms of heart transplant rejection, and has no history of treatment for heart transplant rejection.
03If any required item is not submitted, it could impact the review and decision outcome, and gene expression profiling for patients who do not meet these criteria is considered investigational.
04Providers are encouraged to tell members before rendering investigational or cosmetic services that members are likely to be financially responsible for the cost.

Codes mentioned

8147981558815608159586849

Original notice

Laboratory Tests for Organ Transplant Rejection
beonbrand.getbynder.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account